483 related articles for article (PubMed ID: 2174225)
1. Neuropeptide Y receptor subtypes, Y1 and Y2.
Wahlestedt C; Grundemar L; Håkanson R; Heilig M; Shen GH; Zukowska-Grojec Z; Reis DJ
Ann N Y Acad Sci; 1990; 611():7-26. PubMed ID: 2174225
[TBL] [Abstract][Full Text] [Related]
2. Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YY.
Wahlestedt C; Regunathan S; Reis DJ
Life Sci; 1992; 50(4):PL7-12. PubMed ID: 1310131
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y, peptide YY and C-terminal fragments release histamine from rat peritoneal mast cells.
Grundemar L; Håkanson R
Br J Pharmacol; 1991 Dec; 104(4):776-8. PubMed ID: 1725763
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y and peptide YY: major modulators of gastrointestinal blood flow and function.
Sheikh SP
Am J Physiol; 1991 Nov; 261(5 Pt 1):G701-15. PubMed ID: 1659217
[TBL] [Abstract][Full Text] [Related]
6. Effects of neuropeptide Y (NPY) at the sympathetic neuroeffector junction. Can pre- and postjunctional receptors be distinguished?
Wahlestedt C; Håkanson R
Med Biol; 1986; 64(2-3):85-8. PubMed ID: 3018392
[TBL] [Abstract][Full Text] [Related]
7. PYY and NPY: control of gastric motility via action on Y1 and Y2 receptors in the DVC.
Chen CH; Stephens RL; Rogers RC
Neurogastroenterol Motil; 1997 Jun; 9(2):109-16. PubMed ID: 9198086
[TBL] [Abstract][Full Text] [Related]
8. Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog.
Malmström RE; Hökfelt T; Björkman JA; Nihlén C; Byström M; Ekstrand AJ; Lundberg JM
Regul Pept; 1998 Sep; 75-76():55-70. PubMed ID: 9802394
[TBL] [Abstract][Full Text] [Related]
9. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type.
Larhammar D; Blomqvist AG; Yee F; Jazin E; Yoo H; Wahlested C
J Biol Chem; 1992 Jun; 267(16):10935-8. PubMed ID: 1317848
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
[TBL] [Abstract][Full Text] [Related]
11. Multiple neuropeptide Y receptors are involved in cardiovascular regulation. Peripheral and central mechanisms.
Grundemar L; Håkanson R
Gen Pharmacol; 1993 Jul; 24(4):785-96. PubMed ID: 8224732
[TBL] [Abstract][Full Text] [Related]
12. Y1 and Y2 receptor selective neuropeptide Y analogues: evidence for a Y1 receptor subclass.
Kirby DA; Koerber SC; May JM; Hagaman C; Cullen MJ; Pelleymounter MA; Rivier JE
J Med Chem; 1995 Oct; 38(22):4579-86. PubMed ID: 7473586
[TBL] [Abstract][Full Text] [Related]
13. Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed.
McAuley MA; Westfall TC
J Pharmacol Exp Ther; 1992 Jun; 261(3):863-8. PubMed ID: 1351098
[TBL] [Abstract][Full Text] [Related]
14. Evidence for further heterogeneity of the receptors for neuropeptide-Y and peptide-YY in tumor cell lines derived from neural crest.
Inui A; Sano K; Miura M; Hirosue Y; Nakajima M; Okita M; Baba S; Kasuga M
Endocrinology; 1992 Nov; 131(5):2090-6. PubMed ID: 1330489
[TBL] [Abstract][Full Text] [Related]
15. Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides.
Wahlestedt C; Yanaihara N; Håkanson R
Regul Pept; 1986 Feb; 13(3-4):307-18. PubMed ID: 3010387
[TBL] [Abstract][Full Text] [Related]
16. Activation of neuropeptide Y1 and neuropeptide Y2 receptors by substituted and truncated neuropeptide Y analogs: identification of signal epitopes.
Grundemar L; Krstenansky JL; Håkanson R
Eur J Pharmacol; 1993 Mar; 232(2-3):271-8. PubMed ID: 8467862
[TBL] [Abstract][Full Text] [Related]
17. NPY Y2 receptor agonist, N-acetyl [Leu28,Leu31]NPY24-36, reduces renal vasoconstrictor activity in anaesthetised dogs.
Mahns DA; Kelly C; McCloskey DI; Potter EK
J Auton Nerv Syst; 1999 Oct; 78(1):10-7. PubMed ID: 10589818
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
Malmström RE
Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of Y receptors and signaling pathways in intestinal circular and longitudinal smooth muscle.
Misra S; Mahavadi S; Grider JR; Murthy KS
Regul Pept; 2005 Feb; 125(1-3):163-72. PubMed ID: 15582728
[TBL] [Abstract][Full Text] [Related]
20. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.
Gué M; Junien JL; Reeve JR; Rivier J; Grandt D; Taché Y
Br J Pharmacol; 1996 May; 118(2):237-42. PubMed ID: 8735621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
